BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260610T222611
CREATED:20240618T122844Z
LAST-MODIFIED:20241024T183049Z
UID:10000776-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately allows in-depth investigations across diverse data-sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nIn this webinar you will learn how to \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology related drug target and biomarkers expression patterns in bulk and single cell RNA-seq studies.\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-through-omicsoft-lands-apis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1052_1_QDI_OmicSoft_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260610T222611
CREATED:20240724T173808Z
LAST-MODIFIED:20241024T183054Z
UID:10000784-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deep dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nTopics that will be covered include: \n\nHow to analyze miRNA-seq datasets alone or both miRNA and corresponding mRNA datasets together\nHow to use QIAGEN IPA without a dataset\, using miRNA IDs\nIntroduction to databases and curated content specific to miRNA\nHow to effectively apply various filters and functionalities to identify biomarkers\, key targets and biological mechanisms\n\nLearn more about IPA or request for a trial.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deep-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1032_8_QDI_IPAlandExplorer_Gi1170740969_TME-training_promo_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240724T130000
DTEND;TZID=America/Halifax:20240724T143000
DTSTAMP:20260610T222611
CREATED:20240808T095715Z
LAST-MODIFIED:20241024T182418Z
UID:10000554-1721826000-1721831400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitor and immuno-oncology investigation through OmicSoft Lands APIs
DESCRIPTION:While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data\, such investigation is hindered by the difficulty in finding and combining related datasets to perform large-scale meta-analyses. This webinar will focus on how high quality curated genomic repositories such as the QIAGEN OmicSoft Lands database immediately allows in-depth investigations across diverse data-sources (GEO\, CPTAC\, TCGA\, GTEx and many more) to discover and validate candidate checkpoint inhibitor drug targets and biomarker investigation. \nIn this webinar you will learn how to \n\nEasily identify relevant samples using extensive manually curated clinical metadata\nVisualize and identify checkpoint inhibition biology related drug target and biomarkers expression patterns in bulk and single cell RNA-seq studies.\nReveal how the expression of a group of biomarkers (or genes/proteins of interest) correlates in normal and disease tissue
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitor-and-immuno-oncology-investigation-through-omicsoft-lands-apis-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1052_1_QDI_OmicSoft_16x9-3.jpg
END:VEVENT
END:VCALENDAR